The use of sodium-glucose co-transporter 2 inhibitors in the inpatient setting: Is the risk worth taking?
published in: Journal of Clinical Pharmacy and Therapeutics
date of publication: 2020-01-06
Cites articles
There is nothing here
Article - wd:Q92438636